Insider · CIK 0001522780
Edward M. Kaye MD
ceoofficerdirector
Files at CYTK (CYTOKINETICS INC), RNA (Avidity Biosciences, Inc.), STOK (Stoke Therapeutics, Inc.). First filing Dec 10, 2024, latest Dec 2, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 11
$0 bought, $5.2M sold
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
CYTK: CYTOKINETICS INC
CYTKOct 9, 2026 · close 62.91
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
STOK: Stoke Therapeutics, Inc.
STOKOct 9, 2026 · close 24.74
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | CYTOKINETICS INC | $1.9M 28,064 shares | -74% | +121% from low-3% from high | |
| 20Weak | CYTOKINETICS INC | $337k 5,175 shares | -34% | +123% from low0% from high | |
| 36Weak | CYTOKINETICS INC | $405k 6,757 shares | -41% | +103% from low0% from high | |
| 35Weak | CYTOKINETICS INC | $369k 6,695 shares | -29% | +84% from low-6% from high | |
| 45Moderate | Stoke Therapeutics, Inc. | $1.2M 61,885 shares | -40% | +235% from low-0% from high | |
| 30Weak | CYTOKINETICS INC | $338k 6,756 shares | -23% | +66% from low-15% from high | |
| 42Moderate | Stoke Therapeutics, Inc. | $221k 12,126 shares | -7% | +214% from low0% from high | |
| 25Weak | CYTOKINETICS INC | $117k 3,636 shares | -11% | +8% from low-45% from high | |
| 39Weak | Stoke Therapeutics, Inc. | $164k 19,289 shares | -12% | +20% from low-42% from high | |
| 49Moderate | Stoke Therapeutics, Inc. | $88k 6,786 shares | -10% | +22% from low-10% from high | |
| 49Moderate | Stoke Therapeutics, Inc. | $79k 6,170 shares | -8% | +18% from low-13% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 1, 2025 | CYTK CYTOKINETICS INC | MOption exercise Common Stock10b5-1 | +8,064 | $12.40 | $100k | 18,041 | Dec 2, 2025 |
| Dec 1, 2025 | CYTK CYTOKINETICS INC | MOption exercise Common Stock10b5-1 | +20,000 | $14.25 | $285k | 38,041 | Dec 2, 2025 |
| Dec 1, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -28,064 | $66.72 | $1.9M | 9,977 | Dec 2, 2025 |
| Dec 1, 2025 | CYTK CYTOKINETICS INC | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -8,064 | $0.00 | $0 | 0 | Dec 2, 2025 |
| Dec 1, 2025 | CYTK CYTOKINETICS INC | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -20,000 | $0.00 | $0 | 0 | Dec 2, 2025 |
| Nov 11, 2025 | CYTK CYTOKINETICS INC | MOption exercise Common Stock10b5-1 | +5,175 | $9.66 | $50k | 15,152 | Nov 12, 2025 |
| Nov 11, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -5,175 | $65.08 | $337k | 9,977 | Nov 12, 2025 |
| Nov 11, 2025 | CYTK CYTOKINETICS INC | MOption exercise Non-Qualified Stock Option (Right to Buy)derivative10b5-1 | -5,175 | $0.00 | $0 | 0 | Nov 12, 2025 |
| Oct 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +199 | $62.80 | $12k | 9,977 | Oct 16, 2025 |
| Oct 6, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -6,757 | $60.00 | $405k | 9,778 | Oct 6, 2025 |
| Sep 30, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -6,695 | $55.08 | $369k | 16,535 | Sep 30, 2025 |
| Sep 4, 2025 | STOK Stoke Therapeutics, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -178,500 | $0.00 | $0 | 37,500 | Sep 5, 2025 |
| Sep 4, 2025 | STOK Stoke Therapeutics, Inc. | DDisposition to issuer Restricted Stock Unitsderivative | -144,000 | $0.00 | $0 | 0 | Sep 5, 2025 |
| Aug 29, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -1,029 | $20.00 | $21k | 152,441 | Sep 3, 2025 |
| Sep 2, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -14,860 | $20.14 | $299k | 137,581 | Sep 3, 2025 |
| Sep 3, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -45,996 | $20.13 | $926k | 91,585 | Sep 3, 2025 |
| Sep 2, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -6,756 | $50.00 | $338k | 23,230 | Sep 2, 2025 |
| Aug 18, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -12,126 | $18.24 | $221k | 153,470 | Aug 20, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +26,250 | $0.00 | $0 | 165,596 | Aug 18, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +52,500 | $0.00 | $0 | 52,500 | Aug 18, 2025 |
| Aug 14, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -26,250 | $0.00 | $0 | 26,250 | Aug 18, 2025 |
| Jul 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +328 | $38.01 | $12k | 29,986 | Jul 16, 2025 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Common Stock | +6,692 | $0.00 | $0 | 6,692 | Jun 12, 2025 |
| Jun 10, 2025 | RNA Avidity Biosciences, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,034 | $0.00 | $0 | 10,034 | Jun 12, 2025 |
| Jun 5, 2025 | CYTK CYTOKINETICS INC | SOpen-market sale Common Stock10b5-1 | -3,636 | $32.10 | $117k | 29,658 | Jun 5, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +7,333 | $0.00 | $0 | 33,294 | May 14, 2025 |
| May 14, 2025 | CYTK CYTOKINETICS INC | AGrant or award Non-Qualified Stock Option (Right to Buy)derivative | +10,880 | $0.00 | $0 | 10,880 | May 14, 2025 |
| Apr 15, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +324 | $38.56 | $12k | 25,961 | Apr 16, 2025 |
| Mar 18, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -10,382 | $8.67 | $90k | 148,253 | Mar 20, 2025 |
| Mar 19, 2025 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -8,907 | $8.27 | $74k | 139,346 | Mar 20, 2025 |
| Mar 20, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +216,000 | $0.00 | $0 | 216,000 | Mar 20, 2025 |
| Mar 20, 2025 | STOK Stoke Therapeutics, Inc. | AGrant or award Restricted Stock Unitsderivative | +144,000 | $0.00 | $0 | 144,000 | Mar 20, 2025 |
| Mar 15, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +35,500 | $0.00 | $0 | 132,385 | Mar 18, 2025 |
| Mar 15, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +26,250 | $0.00 | $0 | 158,635 | Mar 18, 2025 |
| Mar 15, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -35,500 | $0.00 | $0 | 71,000 | Mar 18, 2025 |
| Mar 15, 2025 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -26,250 | $0.00 | $0 | 78,750 | Mar 18, 2025 |
| Jan 2, 2025 | CYTK CYTOKINETICS INC | AGrant or award Common Stock | +255 | $48.93 | $12k | 25,637 | Jan 6, 2025 |
| Dec 30, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +35,000 | $0.60 | $21k | 96,885 | Jan 2, 2025 |
| Dec 30, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Employee Stock Option (Right to Buy)derivative | -35,000 | $0.00 | $0 | 567,801 | Jan 2, 2025 |
| Dec 9, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -6,786 | $12.99 | $88k | 61,885 | Dec 11, 2024 |
| Dec 6, 2024 | STOK Stoke Therapeutics, Inc. | SOpen-market sale Common Stock | -6,170 | $12.78 | $79k | 68,671 | Dec 10, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +26,250 | $0.00 | $0 | 74,841 | Dec 10, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +52,500 | $0.00 | $0 | 52,500 | Dec 10, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -26,250 | $0.00 | $0 | 26,250 | Dec 10, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +26,500 | $0.00 | $0 | 75,091 | Dec 5, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | AGrant or award Performance Stock Unitsderivative | +53,000 | $0.00 | $0 | 53,000 | Dec 5, 2024 |
| Dec 3, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Performance Stock Unitsderivative | -26,500 | $0.00 | $0 | 26,500 | Dec 5, 2024 |
| Dec 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Common Stock | +21,591 | $0.00 | $0 | 48,591 | Dec 3, 2024 |
| Dec 1, 2024 | STOK Stoke Therapeutics, Inc. | MOption exercise Restricted Stock Unit (RSU)derivative | -21,591 | $0.00 | $0 | 4,317 | Dec 3, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.